BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21248297)

  • 1. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway.
    Hamano R; Miyata H; Yamasaki M; Kurokawa Y; Hara J; Moon JH; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
    Clin Cancer Res; 2011 May; 17(9):3029-38. PubMed ID: 21248297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced modification of microRNA expression in esophageal cancer.
    Hummel R; Wang T; Watson DI; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
    Oncol Rep; 2011 Oct; 26(4):1011-7. PubMed ID: 21743970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.
    Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs contribute to the chemoresistance of cisplatin in tongue squamous cell carcinoma lines.
    Yu ZW; Zhong LP; Ji T; Zhang P; Chen WT; Zhang CP
    Oral Oncol; 2010 Apr; 46(4):317-22. PubMed ID: 20219416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activation of Akt during preoperative chemotherapy for esophageal cancer correlates with poor prognosis.
    Yoshioka A; Miyata H; Doki Y; Yasuda T; Yamasaki M; Motoori M; Okada K; Matsuyama J; Makari Y; Sohma I; Takiguchi S; Fujiwara Y; Monden M
    Oncol Rep; 2008 May; 19(5):1099-107. PubMed ID: 18425364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
    Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D
    Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN.
    Yang H; Kong W; He L; Zhao JJ; O'Donnell JD; Wang J; Wenham RM; Coppola D; Kruk PA; Nicosia SV; Cheng JQ
    Cancer Res; 2008 Jan; 68(2):425-33. PubMed ID: 18199536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells.
    Fu X; Tian J; Zhang L; Chen Y; Hao Q
    FEBS Lett; 2012 May; 586(9):1279-86. PubMed ID: 22465665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of microRNAs in drug-resistant ovarian cancer cells.
    Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
    Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts.
    Tanaka K; Miyata H; Sugimura K; Fukuda S; Kanemura T; Yamashita K; Miyazaki Y; Takahashi T; Kurokawa Y; Yamasaki M; Wada H; Nakajima K; Takiguchi S; Mori M; Doki Y
    Carcinogenesis; 2015 Aug; 36(8):894-903. PubMed ID: 26026166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells.
    van Jaarsveld MT; Helleman J; Boersma AW; van Kuijk PF; van Ijcken WF; Despierre E; Vergote I; Mathijssen RH; Berns EM; Verweij J; Pothof J; Wiemer EA
    Oncogene; 2013 Sep; 32(36):4284-93. PubMed ID: 23045278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-10b confers cisplatin resistance by activating AKT/mTOR/P70S6K signaling via targeting PPARγ in esophageal cancer.
    Wu K; Hu Y; Yan K; Qi Y; Zhang C; Zhu D; Liu D; Zhao S
    J Cell Physiol; 2020 Feb; 235(2):1247-1258. PubMed ID: 31267531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Interleukin-6 suppresses cisplatin-induced cytotoxicity in esophageal squamous cell carcinoma cells.
    Suchi K; Fujiwara H; Okamura S; Okamura H; Umehara S; Todo M; Furutani A; Yoneda M; Shiozaki A; Kubota T; Ichikawa D; Okamoto K; Otsuji E
    Anticancer Res; 2011 Jan; 31(1):67-75. PubMed ID: 21273582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
    Iizuka N; Hirose K; Noma T; Hazama S; Tangoku A; Hayashi H; Abe T; Yamamoto K; Oka M
    Br J Cancer; 1999 Oct; 81(3):469-75. PubMed ID: 10507772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of the response of esophageal carcinoma cells to cisplatin.
    Takashima N; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Mori R; Tomoda K; Hamaguchi M; Ogawa R; Katada T; Harada K; Fujii Y
    Dis Esophagus; 2008; 21(3):230-5. PubMed ID: 18430104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma.
    Sugihara H; Ishimoto T; Miyake K; Izumi D; Baba Y; Yoshida N; Watanabe M; Baba H
    Int J Mol Sci; 2015 Nov; 16(11):27824-34. PubMed ID: 26610479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor 1 mediates 5-fluorouracil chemoresistance in esophageal carcinoma cells through increasing survivin stability.
    Juan HC; Tsai HT; Chang PH; Huang CY; Hu CP; Wong FH
    Apoptosis; 2011 Feb; 16(2):174-83. PubMed ID: 21082354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.